Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

GeneDx Holdings (WGS) Consolidated Net Income: 2019-2024

Historic Consolidated Net Income for GeneDx Holdings (WGS) over the last 6 years, with Dec 2024 value amounting to -$52.3 million.

  • GeneDx Holdings' Consolidated Net Income rose 8.14% to -$7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 102.50%. This contributed to the annual value of -$52.3 million for FY2024, which is 70.25% up from last year.
  • Per GeneDx Holdings' latest filing, its Consolidated Net Income stood at -$52.3 million for FY2024, which was up 70.25% from -$175.8 million recorded in FY2023.
  • GeneDx Holdings' 5-year Consolidated Net Income high stood at -$52.3 million for FY2024, and its period low was -$548.9 million during FY2022.
  • Over the past 3 years, GeneDx Holdings' median Consolidated Net Income value was -$175.8 million (recorded in 2023), while the average stood at -$259.0 million.
  • Per our database at Business Quant, GeneDx Holdings' Consolidated Net Income slumped by 712.48% in 2020 and then spiked by 70.25% in 2024.
  • GeneDx Holdings' Consolidated Net Income (Yearly) stood at -$241.3 million in 2020, then decreased by 1.68% to -$245.4 million in 2021, then plummeted by 123.70% to -$548.9 million in 2022, then surged by 67.98% to -$175.8 million in 2023, then spiked by 70.25% to -$52.3 million in 2024.